Chairman of the board: Dou Wei, returned overseas students, graduated from China Medical University, majoring in clinical medicine, to teach, engaged in molecular biology, went to Japan TAKARA Central Research Institute of molecular biology gene biology research, RNA synthesis, gene analysis, and other molecular biology-related technology learning, during participation in the Japanese national plan project development of influenza virus vaccine, cancer, AIDS, Japanese young people with white hair and other related diseases gene level research. In recent years, the creation of Liaoning 100 Stubbs Pharmaceutical Biotechnology Institute Co., Ltd., Liaoning 100 European-Biological Technology Co., Ltd., Liaoning Branch Rui think Pharmaceutical Technology Co., Ltd., complete the gene, cell research and clinical application and biomedical products R & D, production and sales Strategic layout, for the treatment of various refractory diseases provides a new way.